Share chart PFIZER
Extended chart
Simple chart
About PFIZER
Pfizer Inc. обнаруживает, разрабатывает, производит, продает, распространяет и продает биофармацевтические продукты по всему миру. Он предлагает лекарства и вакцины в различных терапевтических областях, включая сердечно-сосудистый метаболизм и обезболивание, под торговыми марками Eliquis, Chantix / Champix и Premarin; биопрепараты, малые молекулы, иммунотерапевтические препараты и биоаналоги под брендами Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena и Braftovi; стерильные инъекционные и противоинфекционные препараты торговых марок Сульперазон, Медрол, Зитромакс, Вифенд и Панзига. more details| IPO date | 2012-08-13 |
|---|---|
| ISIN | US7170811035 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 6.37 |
| Дивиденд ао | 1.69 |
| Сайт | http://www.pfizer.com |
| Цена ао | 22.12 |
| Change price per day: | 0% (22.12) |
|---|---|
| Change price per week: | +1.28% (21.84) |
| Change price per month: | -14% (25.72) |
| Change price per 3 month: | -16.24% (26.41) |
| Change price per half year: | -25.45% (29.67) |
| Change price per year: | -14.63% (25.91) |
| Change price per 3 year: | -56.1% (50.39) |
| Change price per 5 year: | -39.78% (36.73) |
| Change price per 10 year: | -36.7% (34.9459) |
| Change price per year to date: | -17.28% (26.74) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard Group Inc | 506517466 | 8.95 |
| Blackrock Inc. | 432503754 | 7.64 |
| State Street Corporation | 287482006 | 5.08 |
| Wellington Management Group, LLP | 239209768 | 4.22 |
| Capital World Investors | 173394272 | 3.06 |
| Geode Capital Management, LLC | 109534217 | 1.93 |
| Charles Schwab Investment Management, Inc. | 104246432 | 1.84 |
| Morgan Stanley | 82106536 | 1.45 |
| Norges Bank Investment Management | 73981480 | 1.31 |
| Massachusetts Financial Services Co. | 68506441 | 1.21 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| John Hancock Multifactor Healthcare ETF | 4.93 | 29.34 | 1.62 |
| Apex Healthcare ETF | 3.92 | 0 | |
| Direxion S&P 500 High minus Low Quality ETF | 2.76 | 27.31 | 14.09 |
| Global Beta Low Beta ETF | 2.42 | 19.88 | 2.09 |
| ROC ETF | 2.21 | 0 | 0.07 |
| Franklin LibertyQ Global Dividend ETF | 2.15 | 30.37 | 2.67 |
| FlexShares Quality Dividend Dynamic Index Fund | 2.13 | 33.57 | 2.42 |
| Global Beta Smart Income ETF | 1.84067 | 0.5684 | 4.99386 |
| iShares Factors US Value Style ETF | 1.71 | 42.34 | 2.98 |
| Nationwide Maximum Diversification U.S. Core Equity ETF | 1.54 | 26.65 | 1.58 |
| Knowledge Leaders Developed World ETF | 1.13981 | 14.17 | 1.90235 |
| Franklin LibertyQ Global Equity ETF | 1.05 | 25.84 | 2.05 |
| iShares Morningstar Large-Cap Value ETF | 0.64297 | 61.02 | 2.17567 |
| First Trust Value Line 100 ETF | 0.63 | 4.14 | 1.17 |
| iShares Morningstar Large-Cap ETF | 0.33152 | 257.57 | 1.41244 |
| Columbia U.S. ESG Equity Income ETF | 0.29579 | -99.18 | 1.44131 |
| JPMorgan Corporate Bond Research Enhanced ETF | 0.21 | 6.26 | 4.16 |
| 1.76 | 28.23 | 2.75 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Jennifer B. Damico | Senior VP, Controller & Principal Accounting Officer | N/A | 1968 (57 years) |
| Ms. Lidia L. Fonseca | Executive VP and Chief Digital & Technology Officer | N/A | 1969 (56 years) |
| Mr. Douglas M. Lankler | Executive VP & General Counsel | 1.76M | 1966 (59 years) |
| Dr. Mikael Dolsten M.D., Ph.D. | Chief Scientific Officer and President of Research & Development | 2.41M | 1958 (67 years) |
| Mr. David M. Denton | Chief Financial Officer & Executive VP | 1.75M | 1965 (60 years) |
| Mr. Rady A. Johnson | Executive VP and Chief Compliance, Quality & Risk Officer | N/A | 1962 (63 years) |
| Dr. Albert Bourla D.V.M., Ph.D. | Chairman of the Board & CEO | 4.05M | 1962 (63 years) |
| Ms. Francesca M. DeMartino | Chief Investor Relations Officer | N/A | |
| Mr. Andreas J. Panayiotou | Global Chief Marketing Officer | N/A | |
| Ms. Payal Sahni Becher | Chief People Experience Officer & Executive VP | 1975 (50 years) |
Address: United States, New York, 235 East 42nd Street - open in Google maps, open in Yandex maps
Website: http://www.pfizer.com
Website: http://www.pfizer.com
